Effects of Flavonoid Fraction of Echinops Mosulensis on Induced Parkinson’s Disease Model in Mice
DOI:
https://doi.org/10.31351/vol33iss(4SI)pp249-260Keywords:
parkinson’s disease, MPTP, Echinops mosulensis.Abstract
Toxins, especially 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), are among the most commonly utilized models of Parkinson's disease (PD) based on the method utilized, MPTP causes different changes like striatal dopamine depletion , and behavioral abnormality. Phytochemical analysis of Echinops mosulensis extract indicated that there was significant amount of flavonoid present in extract. Flavonoids are belonging to several kinds of plant polyphenols exert a potent antioxidant, neuroprotective, and anti-inflammatory properties. The aim of present study was to investigate neuroprotective effect of flavonoid fractions of Iraqi Echinops mosulensis on induced PD model in mice. Forty male mice were randomly arrayed in 4 groups (10 mice in each group). Group 1: healthy normal control group received distilled water orally via gavage tube for 25 days. Group 2: induction group received MPTP (30mg/kg/day) intraperitoneally for 5 consecutive days to achieved model of PD then continue with distilled water orally via gavage tube for 25 days. Group 3: the positive control group administered pramipexole orally (1mg/ kg/ day) for 25 days then the induction was done with MPTP (30mg/kg/day) intraperitoneally 1 hour post-pramipexole from day 15 to 19. Group 4: received flavonoid fraction orally (250 mg/kg/day) for 25 days then the induction was done with MPTP (30mg/kg/ day) intraperitoneally 1 hour post- flavonoid fraction form the day 15 to day 19. At the day 26, the behavior test was done and at the day 27 all animals were sacrificed. Homogenized brain tissue was prepared for analysis. In present study there was significant decreased in Malondialdehyde, interleukin -1beta, cytochrome C, α-synuclein levels of flavonoid fraction accompanied with significant increase in tyrosine hydroxylase level of flavonoid fraction as compared to induction (p≤0.05), as well as significant increase in distance traveled in treated group as compared to induction (p≤0.05) .Additionally, good improvement in histopathological analysis of treated group as compared to induction. In conclusion, flavonoid fraction of E. mosulensis has a neuroprotective effect on MPTP induced PD Model in Mice.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Santoro M, Fadda P, Klephan KJ, Hull C, Teismann P, Platt B, Riedel G. Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's disease. J Neurochem. 2023; 164(2):121-142.
Van Nuland AJM, den Ouden HEM, Zach H, Dirkx MFM, van Asten JJA, Scheenen TWJ, Toni I, Cools R, Helmich RC. GABAergic changes in the thalamocortical circuit in Parkinson's disease. Hum Brain Mapp. 2020; 41(4):1017-1029.
Xue X, Zhang W, Zhu J, Chen X, Zhou S, Xu Z, Hu G, Su C. Aquaporin-4 deficiency reduces TGF-β1 in mouse midbrains and exacerbates pathology in experimental Parkinson's disease. J Cell Mol Med. 2019; 23(4):2568-2582.
Osborne JA, Botkin R, Colon-Semenza C, DeAngelis TR, Gallardo OG, Kosakowski H, Martello J, Pradhan S, Rafferty M, Readinger JL, Whitt AL, Ellis TD. Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association. Phys Ther. 2022; 102(4):pzab302.
Day JO, Mullin S. The Genetics of Parkinson's Disease and Implications for Clinical Practice. Genes (Basel). 2021;12(7):1006.
Koziorowski D, Figura M, Milanowski ŁM, Szlufik S, Alster P, Madetko N, Friedman A. Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences. Cells. 2021;10(3):656.
Shin HW, Hong SW, Youn YC. Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism. J Clin Neurol. 2022; 18(3):259-270.
Costas C, Faro LRF. Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease. Curr Neuropharmacol. 2022; 20(2):432-459.
Bock MA, Brown EG, Zhang L, Tanner C. Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease. Neurology. 2022; 98(22):e2194-e2203.
Atiq A, Lee HJ, Khan A, Kang MH, Rehman IU, Ahmad R, Tahir M, Ali J, Choe K, Park JS, Kim MO. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment. Int J Mol Sci. 2023; 24(12):9942.
Henderson MX, Trojanowski JQ, Lee VM. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Neurosci Lett. 2019; 709:134316.
Gao H, Sun H, Yan N, Zhao P, Xu H, Zheng W, Zhang X, Wang T, Guo C, Zhong M. ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson's Disease Model. Int J Mol Sci. 2022; 23(14):8035.
Burré J. The Synaptic Function of α-Synuclein. J Parkinsons Dis. 2015; 5(4):699-713.
Sian-Hulsmann J, Riederer P. The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels. Cells. 2021; 10(3):598.
Mor DE, Daniels MJ, Ischiropoulos H. The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration. Mov Disord. 2019; 34(2):167-179.
Park H, Chang KA. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model. Int J Mol Sci. 2020; 21(21):8129.
Chang HC, Liu KF, Teng CJ, Lai SC, Yang SE, Ching H, Wu CR. Sophora Tomentosa Extract Prevents MPTP-Induced Parkinsonism in C57BL/6 Mice Via the Inhibition of GSK-3β Phosphorylation and Oxidative Stress. Nutrients. 2019; 11(2):252.
Meredith GE, Rademacher DJ. MPTP mouse models of Parkinson's disease: an update. J Parkinsons Dis. 2011; 1(1):19-33.
Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, Li H, Shen L. Comparison of the effect of rotenone and 1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine on inducing chronic Parkinson's disease in mouse models. Mol Med Rep. 2022; 25(3):91.
Razali K, Mohd Nasir MH, Othman N, Doolaanea AA, Kumar J, Nabeel Ibrahim W, Mohamed WMY. Characterization of neurobehavioral pattern in a zebrafish 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model: A 96-hour behavioral study. PLoS One. 2022; 17(10):e0274844.
Campolo M, Casili G, Biundo F, Crupi R, Cordaro M, Cuzzocrea S, Esposito E. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2. Antioxid Redox Signal. 2017; 27(8):453-471.
Ardah MT, Bharathan G, Kitada T, Haque ME. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease. Biomolecules. 2020; 10(11):1519.
Bitew H, Hymete A. The Genus Echinops: Phytochemistry and Biological Activities: A Review. Front Pharmacol. 2019; 10:1234.
Falah, Fereshteh, et al. In vitro screening of phytochemicals, antioxidant, antimicrobial, and cytotoxic activity of Echinops setifer extract. Biocatalysis and Agricultural Biotechnology, 2021, 35: 102102.
Mahmood, Ammar A. Razzak; Khadeem, Enas J. Phytochemical investigation of flavonoids glycoside in the Iraqi Echinops heterophyllus (Compositae). Pharmacie Globale, 2013, 4.9: 1.
Oubaid, E. N., Abu-Raghif, A. R., & Al-Sudani, I. M Phytochemical Screening and Antioxidant Activity of Uncaria tomentosa Extract: In Vitro: and: In Vivo: Studies. Medical Journal of Babylon. 2023; 20(1), 136-142.
Zheleva-Dimitrova D, Simeonova R, Kondeva-Burdina M, Savov Y, Balabanova V, Zengin G, Petrova A, Gevrenova R. Antioxidant and Hepatoprotective Potential of Echinops ritro L. Extracts on Induced Oxidative Stress In Vitro/In Vivo. Int J Mol Sci. 2023; 24(12):9999.
Khan S, Al-Qurainy F, Al-Hashimi A, Nadeem M, Tarroum M, Shaikhaldein HO, Salih AM. Effect of Green Synthesized ZnO-NPs on Growth, Antioxidant System Response and Bioactive Compound Accumulation in Echinops macrochaetus, a Potential Medicinal Plant, and Assessment of Genome Size (2C DNA Content). Plants (Basel). 2023; 12(8):1669.
Hassan, R. F., & Kadhim, H. M. Exploring the role of phenolic extract as an ointment dosage form in inducing wound healing in mice. Journal of Pharmaceutical Negative Results. 2022; 13(3), 186-193.
Evans JA, Mendonca P, Soliman KFA. Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases. Nutrients. 2022; 14(11):2228.
Zhang X, Molsberry SA, Yeh TS, Cassidy A, Schwarzschild MA, Ascherio A, Gao X. Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study. Neurology. 2022; 98(10):e1064-e1076.
Corona, G., Vauzour, D., Amini, A., & Spencer, J. P. The impact of gastrointestinal modifications, blood-brain barrier transport, and intracellular metabolism on polyphenol bioavailability: an overview. Polyphenols in human health and disease, 2014; 591-604.
Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas AH, Jaremko M. Important Flavonoids and Their Role as a Therapeutic Agent. Molecules. 2020; 25(22):5243.
Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ. Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules. 2022; 27(9):2901.
Hasan S, Khatri N, Rahman ZN, Menezes AA, Martini J, Shehjar F, Mujeeb N, Shah ZA. Neuroprotective Potential of Flavonoids in Brain Disorders. Brain Sci. 2023; 13(9):1258.
Abdulmohsin, H. E. B. A., Raghif, A. A., & Manna, M. J. The protective effects of echinops heterophyllus extract against methotrexate-induced hepatotoxicity in rabbits. Asian. J. Pharm. Clin. Res. 2019; 12, 384-390.
Zhang QS, Heng Y, Mou Z, Huang JY, Yuan YH, Chen NH. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. Acta Pharmacol Sin. 2017; 38(10):1317-1328.
Elhak SG, Ghanem AA, Abdelghaffar H, Eldakroury S, Eltantawy D, Eldosouky S, Salama M. The role of pramipexole in a severe Parkinson's disease model in mice. Ther Adv Neurol Disord. 2010; 3(6):333-7.
Hu M, Li F, Wang W. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway. Drug Des Devel Ther. 2018; 12:565-573.
Nordquist, Rebecca E., et al. "Pigs as model species to investigate effects of early life events on later behavioral and neurological functions." Animal models for the study of human disease. Academic Press, 2017; 1003-1030.
Sáenz, J. C. B., Villagra, O. R., & Trías, J. F. Factor analysis of forced swimming test, sucrose preference test and open field test on enriched, social and isolated reared rats. Behavioural brain research, 2006; 169(1), 57-65.
Tatem KS, Quinn JL, Phadke A, Yu Q, Gordish-Dressman H, Nagaraju K. Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J Vis Exp. 2014; (91):51785.
Sun C, Wang Y, Mo M, Song C, Wang X, Chen S, Liu Y. Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson's Disease Rat Model. Biomed Res Int. 2019; 2019: 6843265.
Fadhel, Mohammed H.; Hassan, Ali F. Protective Effect of Omega-7 against Doxorubicin-Induced Cardiotoxicity in Male Rats. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512), 2023, 32.3: 35-40.
https://www.elabscience.com/List-detail-259.html
Alkhazragy, Baidaa; Alshawi, Nada N. Protective Effect of Cranberry Extract against Cisplatin-Induced Nephrotoxicity by Improving Oxidative Stress in Mice. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512), 2023, 32.2: 112-119.
Mbiydzenyuy NE, Ninsiima HI, Valladares MB, Pieme CA. Zinc and linoleic acid pre-treatment attenuates biochemical and histological changes in the midbrain of rats with rotenone-induced Parkinsonism. BMC Neurosci. 2018;19(1):29.
Bancroft, J.D. and Stevens, A. Theory and Practice of Histological Techniques. 3rd ed., Churchill Livingstone. 1990; P: 25-60.
Rasheed, M. Z., Andrabi, S. S., Salman, M., Tabassum, H., Shaquiquzzaman, M., Parveen, S., & Parvez, S. Melatonin improves behavioral and biochemical outcomes in a rotenone-induced rat model of Parkinson's disease. Journal of Environmental Pathology, Toxicology and Oncology, 2018; 37(2).
Bloomingdale P, Karelina T, Ramakrishnan V, Bakshi S, Véronneau-Veilleux F, Moye M, Sekiguchi K, Meno-Tetang G, Mohan A, Maithreye R, Thomas VA, Gibbons F, Cabal A, Bouteiller JM, Geerts H. Hallmarks of neurodegenerative disease: A systems pharmacology perspective. CPT Pharmacometrics Syst Pharmacol. 2022 ;11(11):1399-1429.
Ugalde-Muñiz P, Fetter-Pruneda I, Navarro L, García E, Chavarría A. Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model. Oxid Med Cell Longev. 2020; 2020:4807179.
Chonpathompikunlert P, Boonruamkaew P, Sukketsiri W, Hutamekalin P, Sroyraya M. The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice. BMC Complement Altern Med. 2018; 18(1):103.
Wang LY, Yu X, Li XX, Zhao YN, Wang CY, Wang ZY, He ZY. Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease. Front Aging Neurosci. 2019; 11:316.
Jackson Seukep A, Zhang YL, Xu YB, Guo MQ. In Vitro Antibacterial and Antiproliferative Potential of Echinops lanceolatus Mattf. (Asteraceae) and Identification of Potential Bioactive Compounds. Pharmaceuticals (Basel). 2020; 13(4):59.
Saadullah M, Arif S, Hussain L, Asif M, Khurshid U. Dose Dependent Effects of Breynia cernua Against the Paraquat Induced Parkinsonism like Symptoms in Animals' Model: In Vitro, In Vivo and Mechanistic Studies. Dose Response. 2022; 20(3):15593258221125478.
Magalingam KB, Radhakrishnan AK, Haleagrahara N. Protective Mechanisms of Flavonoids in Parkinson's Disease. Oxid Med Cell Longev. 2015; 2015:314560.
Behl T, Kaur G, Sehgal A, Zengin G, Singh S, Ahmadi A, Bungau S. Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease. Curr Neuropharmacol. 2022; 20(2):324-343.
Pan, X., Liu, X., Zhao, H., Wu, B., & Liu, G. Antioxidant, anti-inflammatory and neuroprotective effect of kaempferol on rotenone-induced Parkinson’s disease model of rats and SH-S5Y5 cells by preventing loss of tyrosine hydroxylase. Journal of Functional Foods, 2020; 74, 104140.
Nikokalam Nazif N, Khosravi M, Ahmadi R, Bananej M, Majd A. Effect of treadmill exercise on catalepsy and the expression of the BDNF gene in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine -induced Parkinson in male NMRI mice. Iran J Basic Med Sci. 2020; 23(4):483-493.
Benchikha N, Messaoudi M, Larkem I, Ouakouak H, Rebiai A, Boubekeur S, Ferhat MA, Benarfa A, Begaa S, Benmohamed M, Almasri DM, Hareeri RH, Youssef FS. Evaluation of Possible Antioxidant, Anti-Hyperglycaemic, Anti-Alzheimer and Anti-Inflammatory Effects of Teucrium polium Aerial Parts (Lamiaceae). Life (Basel). 2022; (10):1579.
Wang WW, Han R, He HJ, Li J, Chen SY, Gu Y, Xie C. Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models. Aging (Albany NY). 2021; 13(8):11738-11751.
Ait Lhaj Z, Ibork H, El Idrissi S, Ait Lhaj F, Sobeh M, Mohamed WMY, Alamy M, Taghzouti K, Abboussi O. Bioactive strawberry fruit (Arbutus unedo L.) extract remedies paraquat-induced neurotoxicity in the offspring prenatally exposed rats. Front Neurosci. 2023; 17:1244603.
Wang, D. M., Li, S. Q., Zhu, X. Y., Wang, Y., Wu, W. L., & Zhang, X. J. Protective effects of hesperidin against amyloid-β (Aβ) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells. Neurochemical research, 2013; 38, 1034-1044.
Meng, X., Munishkina, L. A., Fink, A. L., & Uversky, V. N. Effects of various flavonoids on the α‐synuclein fibrillation process. Parkinson’s Disease, 2010; 2010(1), 650794.
Kosmowska B, Ossowska K, Wardas J. (2020). Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor. Neurochem Res. 45(7):1518-1525.
Spencer JP. Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr. 2009 ;4(4):243-50.
Castro ES, Santos-García D, de Deus Fonticoba T, Expósito Ruíz I, Tuñas Gesto C, Arribí MM. Causes and factors related to dopamine agonist withdrawal in Parkinson's disease. Brain Behav.2016; 6(7):e00453.
Borovac JA. Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology. Yale J Biol Med. 2016;89(1):37-47.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
